Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171726 | SCV000055235 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000530961 | SCV000627766 | benign | Long QT syndrome | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619253 | SCV000737874 | likely benign | Cardiovascular phenotype | 2017-01-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Advanced Laboratory Medicine, |
RCV000853024 | SCV000995781 | benign | Cardiomyopathy | 2019-01-31 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001333447 | SCV001526019 | uncertain significance | Long QT syndrome 11 | 2018-12-28 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000171726 | SCV001787372 | likely benign | not provided | 2019-11-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230433 | SCV003928242 | likely benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing |